Items where authors include "Ford, K"

Article

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Denman, S, Ford, K, Toolan, J et al. (4 more authors) (2016) Home Self-Administration of Omalizumab for Chronic Spontaneous Urticaria. British Journal of Dermatology, 175 (6). pp. 1405-1407. ISSN 0007-0963

Conference or Workshop Item

Corps, C, Denman, S, Ford, K et al. (5 more authors) (2017) Short course specific immunotherapy for seasonal allergic rhinoconjunctivitis and its impact on quality of life. In: European Academy of Allergy and Clinical Immunology Congress (EAACI 2017), 17-21 Jun 2017, Helsinki, Finland.

Denman, S, Toolan, J, Ford, K et al. (5 more authors) (2017) The impact of the introduction of icatibant on A&E attendance, hospital admissions and acute treatment episodes in patients with hereditary angioedema. In: European Academy of Allergy and Clinical Immunology Congress (EAACI 2017), 17-21 Jun 2017, Helsinki, Finland.

Proceedings Paper

Savic, L, Hopkins, P orcid.org/0000-0002-8127-1739, Ford, K et al. (2 more authors) (2019) Drug provocation testing (DPT) to exclude neuromuscular blocking agent (NMBA) allergy: a case report. In: Clinical and Experimental Allergy. BSACI Annual Meeting, 03-05 Oct 2019, Harrogate, UK. , p. 1664.